Autor: |
Martin, Andy, Pemberton, Tim, Crump, Neil, Christensen, Lawrence |
Předmět: |
|
Zdroj: |
PRWeek (London); 2/27/2009, p26-27, 2p |
Abstrakt: |
Several letters to the editor are presented in response to articles in previous issues including Ian Monk's "Results-Based PR Can Be Dangerous," in the February 20, 2009 issue, GlaxoSmithKline's move to supply patented drugs to the developing world at a 75 percent discount, in the February 20, 2009 issue and a public relation's issue on other companies doing well in the industry. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|